Q: WHAT IS THE COLLABORATION BETWEEN DUKE UNIVERSITY AND DEERFIELD MANAGEMENT?
A: Duke is collaborating with Deerfield, an investment firm dedicated to advancing healthcare, to accelerate the translation of research in Duke faculty laboratories into clinical therapeutics. Four Points is a Deerfield company that will support Duke's innovative translational research and leverage Deerfield's expertise in accelerating state-of-the-art drug development. Four Points will fund projects with the aim of discovering novel therapeutics to cure life-altering diseases.
Through Four Points, Deerfield has committed up to $130 million in initial funding to support promising Duke translational research. This collaboration will provide operational support and may make additional capital investments into spin-off companies that emerge from Four Points projects that show commercial potential.
Q: WHO IS ELIGIBLE TO APPLY?
A: Principal Investigators whose principal employer is Duke University or Duke University Health System or who have a faculty appointment at Duke University and are therefore subject to Duke's institutional policies are eligible to apply.
Q: HOW CAN I APPLY?
A: Applicants are encouraged to contact Bryan Baines (email@example.com) for more information on submission to Four Points.
Q: DOES FOUR POINTS HAVE A THERAPEUTIC AREA OF INTEREST?
A: No - We welcome applications from all therapeutic areas.